Pharma: Clinic Roundup
Tuesday, October 9, 2012
Grifols SA, of Barcelona, Spain, said the first patient was enrolled and dosed in a Phase II study testing Alpha-1 HC aerosol in cystic fibrosis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.